Sanofi files suit in the U.S. to defend its patent rights on Lantus®. Sanofi filed a patent infringement suit against Merck Sharp & Dohme Corp. on August 8, 2017 in the United States District Court for the District of New Jersey. In its suit Sanofi alleges infringement of two patents. The suit was triggered by a notification…
Takeda & TESARO to Develop & Commercialize Tumor Drug in Japan
TESARO and Takeda enter into exclusive licensing agreement to develop and commercialize novel cancer therapy niraparib in Japan. TESARO, Inc. and Takeda Pharmaceutical Company Limited announced an exclusive licensing agreement for the commercialization and clinical development of niraparib, a novel poly ADP-ribose polymerase (PARP) inhibitor. This agreement includes the development of niraparib for the treatment of all…